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Ovarian cancer is the fifth leading cause of cancer death among women in the U.S. and 
kills approximately 14,000 women each year (Nezhat et al., 2015).  Survival increases with early 
diagnosis; the five-year survival rate in stage I is 90%.  Symptoms are vague and common to 
many health diseases, which may well explain why upwards of 70% of women with ovarian 
cancer are diagnosed at stage III or IV (Slatnik & Duff, 2015).  Preventative guidelines in the 
U.S. do not recommend screening for ovarian cancer in women of average risk (AAFP, 2016b; 
ACOG, 2011; Doubeni et al., 2016; Moyer, 2012; NCCN, 2015; Qaseem et al., 2014; Wilt et al., 
2015).  A lack of screening recommendations and a subtle presentation point to the need for 
greater healthcare professional recognition of symptoms and risk factors of ovarian cancer, 
which can then lead to a prompt diagnosis.   
While healthcare professionals have the opportunity to improve women’s health, gaps in 
knowledge exist related to ovarian cancer risk factors and symptom recognition (Gajjar et al., 
2012).  Continuing education improves healthcare professionals’ performance and patient health 
outcomes (Cervero & Gaines, 2015).  Increasing healthcare professionals’ knowledge of ovarian 
cancer may help to detect ovarian cancer in earlier stages and enhance health outcomes of 
women.   
Based on the need for an increase in awareness and knowledge among healthcare 
professionals, a local ovarian cancer conference was developed and offered to healthcare 
professionals.  The conference focused on presenting ovarian cancer risk factors and symptoms.  
Attendees were provided with an ovarian cancer resource for patient education.   
The conference was evaluated through pretests and posttests and a conference evaluation 
survey.  Data was collected the evening of the conference with 29 attendees responding.  After 
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the conference, correct responses increased in the areas of risk factor and symptom recognition.  
The number of correct responses increased from 106 on the pretest to 122 on the posttest.  In 
regards to ability to educate women about ovarian cancer, 62% of respondents indicated that they 
were “very confident” in their ability.    
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CHAPTER ONE. INTRODUCTION 
Background and Significance 
Ovarian cancer is the deadliest of all gynecologic cancers and the second most common 
(Carlson, 2016; Chen & Berek, 2015; Doubeni, Doubeni, & Myers, 2016; Nezhat, Apostol, 
Nezhat, & Pejovic, 2015).  A woman’s lifetime risk of developing ovarian cancer is 1 in 76 or 
1.31% (ACS, 2016; National Cancer Institute, 2015).  Each year in the United States (U.S.) there 
are approximately 22,000 new cases of ovarian cancer diagnosed.  Approximately 14,000 
women die of the disease each year, making it the fifth leading cause of cancer death in women 
(Crull, Mayer, & Jessup, 2014; Nezhat et al., 2015).  The average age of women at diagnosis of 
ovarian cancer is 63 years (Crull et al., 2014).   
Ovarian cancer survival increases with early diagnosis.  The five-year survival rate of 
stage I ovarian cancer is 90% (Carlson, 2016).  The five-year survival rate of stage III and of 
stage IV ovarian cancer is 20% and 6%, respectively.  More than 70% of women with ovarian 
cancer are diagnosed at stage III or IV while only about 30% are diagnosed at stage I (Slatnik & 
Duff, 2015).  Early detection leads to better outcomes.   
Symptoms of ovarian cancer are vague and understated–adding to the lethality (Slatnik & 
Duff, 2015).  Preventative guidelines in the U.S. do not recommend screening for ovarian cancer 
in women of average risk (AAFP, 2016b; ACOG, 2011; Doubeni et al., 2016; Moyer, 2012; 
NCCN, 2015; Qaseem, Humphrey, Harris, Starkey, & Denberg, 2014; Wilt, Harris, & Qaseem, 
2015).  A lack of screening recommendations and a subtle presentation point to the need for 
greater healthcare professional recognition of symptoms and risk factors of ovarian cancer, 
which can then lead to a prompt diagnosis.   
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The Ovarian Cancer National Alliance (OCNA) ranked each state in the U.S. on quality 
of care of women with ovarian cancer.  Rankings were based on access to care, education and 
awareness, quality of life, and research support.  The state of North Dakota scored 50th out of 51 
states (including the District of Columbia) on the OCNA report card (OCNA, 2016).  North 
Dakota’s poor ranking indicates the need to improve the quality of care for women with ovarian 
cancer in the state.   
Problem Statement 
Despite advances in healthcare throughout the years, ovarian cancer remains the most 
lethal gynecological cancer.  Educating healthcare professionals about ovarian cancer offers an 
opportunity to learn or refresh knowledge about risk factors for and symptoms of ovarian cancer.  
Healthcare professionals can use this knowledge to aid in early detection and effect patient 
outcomes.   
Project Description  
The purpose of this project was to increase awareness and knowledge of ovarian cancer 
among healthcare professionals.  An ovarian cancer educational conference was designed and 
offered to healthcare professionals.  The following objectives were used to guide the project: 1) 
design and organize a local ovarian cancer educational conference for healthcare professionals, 
2) increase awareness and knowledge about ovarian cancer among regional healthcare 
professionals, and 3) provide healthcare professionals with a resource for patient education.  The 
project’s design is explained further in Chapter 3.    
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CHAPTER TWO. REVIEW OF THE LITERATURE 
Introduction 
Among women, ovarian cancer is the fifth deadliest cancer and is the most lethal 
gynecological cancer (ACS, 2014; Doubeni et al., 2016).  The American Cancer Society (2014) 
estimated that in the U.S., 22,280 women would be diagnosed with ovarian cancer and 14,240 
would die from the disease in 2016.  Among women worldwide in 2008, ovarian cancer was 
ranked the seventh most common cancer.  In the same year, there were 225,500 new cases of 
ovarian cancer diagnosed throughout the world (Carlson, 2016).  Very little improvements have 
been made on the incidence and mortality rates of ovarian cancer in the past forty years (Doubeni 
et al., 2016).   
Ovarian cancer affects one in 76 women (ACS, 2016; National Cancer Institute, 2015).  
Incidence increases with age and the disease is more commonly diagnosed after menopause, 
most commonly in women 55-64 years of age (Doubeni et al., 2016; Rooth, 2013).  Besides age, 
other risk factors include family history, reproductive history, use of hormones, and lifestyle 
choices (Carlson, 2016; Chen & Berek, 2016; Rooth, 2013).  The financial burden of ovarian 
cancer on a woman is significant and is usually upwards of $100,000 (Urban, He, Alfonso, 
Hardesty, & Goff, 2015).  Presenting symptoms are often vague and nonspecific (Slatnik & Duff, 
2015).  An early diagnosis is often related to a more favorable outcome (Doubeni et al., 2016; 
Rooth, 2013).  In women of average risk, screening for ovarian cancer is not recommended 
(AAFP, 2016b; ACOG, 2011; Doubeni et al., 2016; Moyer, 2012; NCCN, 2015; Qaseem et al., 
2014; Wilt et al., 2015).  Most diagnoses of ovarian cancer are made in later stages (Slatnik & 
Duff, 2015).   
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Healthcare professional is a broad term.  For the project, the term healthcare professional 
is defined as individuals from the following groups: physicians, nurse practitioners (NP), 
physician assistants, nurse midwives, nurses, pharmacists, nursing students, and pharmacy 
students.  Individuals in the aforementioned groups are likely to provide care to women and are 
in a position to provide education.   
A primary care provider is often “the entry point for substantially all of the patient’s 
medical and healthcare needs” (AAFP, 2016a).  NPs may provide primary care to patients 
(AAFP, 2016a).  NPs “focus on health promotion, disease prevention, and health education” 
(American Association of Nurse Practitioners, 2017).  Since primary care NPs are often the 
gatekeepers into the healthcare system and the NP profession emphasizes health promotion and 
education, NPs should be knowledgeable about ovarian cancer.   
The project’s purpose is to provide an educational opportunity about ovarian cancer to 
healthcare professionals.  Through an opportunity to learn, it is hoped that knowledge is gained 
and, in the future, health outcomes of women with ovarian cancer are improved.  This chapter is 
a review of literature about types of ovarian cancer, tumor staging, risk factors, symptoms, 
screening recommendations, diagnosis, healthcare professionals’ knowledge of ovarian cancer, 
women’s knowledge of ovarian cancer, and continuing education.  The framework that will 
guide this project is also discussed.   
Ovarian Cancer 
Tumor Types 
Three main types of ovarian cancers exist: epithelial, germ cell, and sex cord-stromal 
tumors.  Tumors are categorized based on the types of cells and tissue from which they are 
derived (Rooth, 2013).  Epithelial ovarian tumors develop from epithelial cells on the surface of 
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the ovary.  Epithelial tumors are the most common type of ovarian cancer, making up 90-95% of 
ovarian cancers (Carlson, 2016; Chen & Berek, 2016; NCCN, 2015).  The remaining 5-10% of 
ovarian cancer is either germ cell tumors or sex cord-stromal tumors (Chen & Berek, 2016).  
Germ cell tumors develop from primeval germ cells of the ovary (Gershenson, 2016a).  Sex 
cord-stromal tumors arise from gonadal stroma and sex cords (Gershenson, 2015).   
Detection and diagnosis of ovarian cancer are the same for the three tumor types.  
Diagnosis of tumor type is made by histological examination, often during surgery (Chen & 
Berek, 2016; Gershenson, 2016a; Gershenson, 2016b).  Sex cord-stromal tumors are often 
diagnosed at an earlier stage than epithelial tumors (Gershenson, 2016b).  Germ cell tumors are 
often diagnosed at stage I (Gershenson, 2014).  Germ cell tumors are more likely to develop in 
women between 10-30 years of age (Gershenson, 2016a).   
Treatment of ovarian cancer varies depending on tumor type and stage (Rooth, 2013).  
Treatment of malignant germ cell tumors is similar to treatment of malignant epithelial tumors 
(Gershenson, 2014).  Malignant sex cord-stromal tumors are most often treated solely with 
surgery (Gershenson, 2016b).   
Staging 
The outcome of an ovarian cancer diagnosis often depends on the tumor stage.  In Stage 
I, the cancer does not extend beyond the ovary(s).  In Stage II, the tumor involves extension 
beyond the ovary but is limited to the pelvis.  A diagnosis of Stage III ovarian cancer denotes 
that the tumor extends outside the pelvis and includes involvement of regional lymph nodes.  
Distant metastasis is requisite for a Stage IV classification (Doubeni et al., 2016; Rooth, 2013).   
Survival rate often depends on cancer stage.  The overall five-year survival rate of 
women diagnosed with ovarian cancer is under 45% (Carlson, 2016).  In women with stage I 
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ovarian cancer, the five-year survival rate is 90% (Carlson, 2016; Slatnik & Duff, 2015).  The 
five-year survival rate of stage IV ovarian cancer is much lower, at 6% in many cases.  More 
than 70% of women with ovarian cancer are diagnosed in later stages (stage III or IV), while 
only about 30% are diagnosed in the earliest stages (Slatnik & Duff, 2015).   
Risk Factors 
Several factors may increase a woman’s risk for ovarian cancer.  Both modifiable and 
non-modifiable factors have been found to increase the risk of ovarian cancer.  Factors include 
family history, genetics, increasing age, reproductive history, use of hormones, and lifestyle 
choices (Carlson, 2016; Chen & Berek, 2016; Rooth, 2013).   
Family history is the strongest risk factor for the development of ovarian cancer (Carlson, 
2016).  A positive family history of ovarian cancer is present in about 10-15% of women who 
develop ovarian cancer.  Risk increases in the instance of a sporadic case of ovarian cancer, but 
risk is significantly greater when a hereditary cancer syndrome (breast-ovarian cancer syndrome 
or Lynch II syndrome) is present (Carlson, 2016).  About 5-15% of ovarian cancers occur in 
women with breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) tumor suppressor gene 
mutations (Rooth, 2013).  Women with a BRCA1 mutation, have a 35-45% lifetime absolute risk 
of developing ovarian cancer.  A BRCA2 mutation carries a 15-25% risk (Carlson, 2016).   
As mentioned earlier, ovarian cancer risk increases with age.  Over half of ovarian 
cancers are diagnosed in women over 65 years.  The average age of women at diagnosis of 
ovarian cancer is 63 years (Crull et al., 2014).  Ovarian cancer diagnosed at a later age decreases 
the likelihood that the cancer is linked to a gene mutation (Carlson, 2016).   
Reproductive history is linked to ovarian cancer risk.  Nulliparity, early menarche (before 
age 12), and late menopause (after age 50) increase risk of developing ovarian cancer (Chen & 
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Berek, 2016).  Infertility, endometriosis, polycystic ovarian syndrome, and pelvic inflammatory 
disease also may increase ovarian cancer risk (Carlson, 2016; Chen & Berek, 2016; Crull et al., 
2014; Rooth, 2013).  Suppression of ovulation by pregnancy, breastfeeding, and oral 
contraceptive pill (OCP) use, appear to decrease a woman’s risk (Carlson, 2016; Rooth, 2013).  
Use of oral contraceptives for five or more years has been associated with a 50% risk reduction 
compared to those who have never used oral contraceptives.  Researchers are uncertain whether 
those who carry the BRCA1 or BRCA2 mutations are included in the reduced risk with OCP use 
(Chura, 2015; Rooth, 2013).   
Other factors that present varying degrees of increased risk for developing ovarian cancer 
include hormone replacement therapy (HRT), lifestyle factors, and ethnic background (Chen & 
Berek, 2016; Rooth, 2013).  Researchers have concluded that long-term use of HRT increases 
risk of ovarian cancer; incidence is increased by one added occurrence of ovarian cancer per 
2,500 users of HRT and mortality is increased by one extra death per 3,300 users of HRT (Chen 
& Berek, 2016; Million Women Study Collaborators, 2007; Rooth, 2013).  Unopposed estrogen 
use after menopause may have a higher risk of ovarian cancer compared with estrogen-progestin 
therapy (Chen & Berek, 2016; Crull et al., 2014).  A woman’s lifestyle may lead to an increased 
risk of ovarian cancer.  Lifestyle factors that increase risk include smoking, obesity, lack of 
exercise, high-fat diet, and perineal talcum powder use (Crull et al., 2014).  Women of 
Ashkenazi Jewish, French Canadian, Dutch, and Icelandic descent may be genetically more 
susceptible (Slatnik & Duff, 2015).   
Symptoms 
Ovarian cancer was often referred to as a “silent disease” or a “silent killer” due to a lack 
of recognizable signs and symptoms of the disease (Goff et al., 2007).  Researchers have since 
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verified that up to 95% of women report experiencing symptoms prior to their diagnosis of 
ovarian cancer (Goff et al., 2007).  Symptoms of ovarian cancer are often subtle and nonspecific 
(Slatnik & Duff, 2015).   
Gastrointestinal, urinary, and gynecological symptoms are the more common presenting 
complaints (Crull et al., 2014).  Most often, symptoms are gastrointestinal in nature: abdominal 
distension, nausea, dyspepsia, early satiety, diarrhea, and constipation.  Urinary frequency or 
urgency is also common (Chura, 2015).  Other symptoms may include a recent unexplained 
increase in abdominal size, bloating, back or abdominal pain, loss of appetite, change in bowel 
habits (constipation or diarrhea), unexplained weight loss or gain, and suspected new diagnosis 
of irritable bowel syndrome (especially in those over age 50).  Fatigue, pelvic pressure or pain, 
postmenopausal bleeding, menstrual irregularities, and rectal bleeding are other possible 
symptoms of ovarian cancer (Slatnik & Duff, 2015).   
Screening Recommendations 
The purpose of cancer screening is to detect malignancies and detect the cancer at an 
earlier stage.  Ovarian cancer screening methods are pelvic examination, tumor biomarkers, 
ultrasonography, or combinations of these methods.  Currently there are no clinical guidelines in 
North America that recommend screening for ovarian cancer in average risk women (AAFP, 
2016b; ACOG, 2011; Doubeni et al., 2016; Moyer, 2012; NCCN, 2015; Qaseem et al., 2014; 
Wilt et al., 2015).   
Screening for ovarian cancer also carries possible risks (Carlson, 2016).  A false positive 
screening result may lead to unnecessary surgical procedures, increased potential complications, 
psychological effects, and financial costs (Carlson, 2016).  A protocol for ovarian cancer 
screening should yield a positive predictive value (PPV) of at least 10%.  To achieve a PPV of 
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greater than or equal to 10%, the screening protocol would need to have a sensitivity of at least 
75% and a specificity of at least 99.6% (Carlson, 2016; Crull et al., 2014; Schorge et al., 2010).   
For women of average risk, preventative guidelines in the U.S. do not recommend 
screening for ovarian cancer (Doubeni et al., 2016; Qaseem et al., 2014; Wilt et al., 2015).  The 
U.S. Preventive Services Task Force (USPSTF) recommends against screening for ovarian 
cancer in asymptomatic women, a grade D recommendation.  The USPSTF recommendation 
does not pertain to women with a known genetic mutation increasing their ovarian cancer risk 
(Moyer, 2012).  The American College of Physicians (ACP) recommends against screening 
pelvic examinations in asymptomatic women of average risk (Qaseem et al., 2014).  The Society 
of Gynecologic Oncology (SGO) recommends that asymptomatic women at low risk for ovarian 
cancer not be screened with cancer antigen-125 (CA-125) or ultrasound (Schorge et al., 2010).   
Several expert groups recommend screening for ovarian cancer in specific populations of 
women.  The National Comprehensive Cancer Network recommends high-risk women be 
offered screening with CA-125 measurement and transvaginal ultrasonography every six months 
(ACOG, 2011).  The SGO recommends that high-risk women, those who are BRCA1 or BRCA2 
mutation carriers, be screened with pelvic exam, CA-125, and transvaginal ultrasonography 
every six months starting at 35 years of age, or 5 to 10 years before the earliest age of first 
diagnosis of ovarian cancer in the family (Schorge et al., 2010).  The American College of 
Obstetricians and Gynecologists (ACOG) recommends, for those with a BRCA mutation, 
beginning transvaginal ultrasonography and CA-125 screening between 30 and 35 years of age 
or 5 to 10 years before the earliest age of ovarian cancer diagnosed in the family (ACOG, 2009).   
Researchers who conducted the Prostate, Lung, Colorectal and Ovarian Cancer Screening 
Trial (Buys et al., 2011) and the United Kingdom Collaborative Trial of Ovarian Cancer 
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Screening (Jacobs et al., 2016) examined the impact of screening methods on ovarian cancer 
mortality.  Buys et al. (2011) studied over 68,000 women between 55-74 years of age in the U.S.  
The women were randomized into two groups: annual screening with CA-125 and transvaginal 
ultrasound or usual care.  In the screening group, there were 118 ovarian cancer deaths compared 
to 100 deaths from ovarian cancer in the usual care group.  Overall mortality was not reduced by 
routine screening (Buys et al., 2011).  Jacobs et al. (2016) studied 202,638 postmenopausal 
women in the United Kingdom (U.K.) over a period of 11 years.  The women were randomly 
assigned to one of three groups: no screening, annual screening with transvaginal ultrasound, or 
multimodal screening with CA-125 and a risk of ovarian cancer algorithm (ROCA).  The ROCA 
assigned women to normal (annual CA-125 screening), intermediate (CA-125 testing repeated in 
3 months), and elevated (CA-125 testing repeated in 6 weeks and transvaginal ultrasound) 
categories based upon risk.  There was a 15% reduction in mortality in the multimodal screening 
group and an 11% reduction in the ultrasound group.  The two-stage screening approach (CA-
125 and ROCA) had a specificity of 99.9% and positive predictive value of 40% for identifying 
invasive ovarian cancer (Jacobs et al., 2016).  The main difference between the two studies is the 
use of CA-125 with one cut-off value versus a two-stage approach with the ROCA (Siwek, 
2016).   
Diagnosis 
Since over 70% of women are diagnosed in later stages of the disease, ovarian cancer is 
considered one of the deadliest gynecologic cancers (Slatnik & Duff, 2015).  An early diagnosis 
is often related to a more favorable outcome.  Five-year survival rate of stage I ovarian cancer is 
90% compared to the 6% survival rate of stage IV (Slatnik & Duff, 2015).  Many methods are 
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available to detect ovarian cancer: symptom index, pelvic examination, tumor biomarkers, and 
ultrasound (Crull et al., 2014; Doubeni et al., 2016; Rooth, 2013).   
Symptom Index 
Goff et al. (2007) created an ovarian cancer symptom index to help clinicians identify 
women with ovarian cancer.  Pelvic pain, abdominal pain, bloating, increased abdominal girth, 
difficulty eating, and early satiety make up the symptom index.  The index is considered positive 
if any of the six symptoms occur more than 12 times per month over a period of less than 12 
months.  In early-stage disease, the symptom index has a sensitivity of 56.7% and 79.5% for 
advanced-stage disease.  Specificity of the symptom index in women less than 50 years of age 
was 86.7% and 90% in women greater than 50 years of age (Goff et al., 2007).   
Pelvic Examination 
Ovarian tumors can be detected during routine bimanual pelvic examination.  During a 
pelvic examination, the ovaries are palpated for size, shape, and consistency (ACS, 2014).  Due 
to the location of the ovary, early stage tumors are not often found.  Tumors detected by 
palpation are usually in advanced stages (Carlson, 2016).   
Tumor Biomarkers 
Over 200 possible tumor biomarkers have been identified for ovarian cancer (Rooth, 
2013).  A biomarker is a biological molecule found within the body that is an indicator of a 
normal or abnormal process.  Tumor biomarker levels rise in response to tissue damage caused 
by a proliferating tumor.  CA-125 and human epididymis protein 4 (HE4) are two biomarkers 
that are used to assess for ovarian cancer (Rooth, 2013).   
CA-125 is a tumor biomarker used to detect ovarian cancer, rising in the presence of 
tissue damage.  The level can also be elevated in other diagnoses such as endometriosis, uterine 
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leiomyoma, cirrhosis, pelvic inflammatory disease, pleural or peritoneal fluid, or cancers of the 
lung, breast, endometrium, and pancreas (Carlson, 2016; Rooth, 2013).  CA-125 levels can differ 
with age, ethnicity, and smoking status.  For example, levels are lower in non-whites and in 
current smokers; levels increase with age.  The normal value of CA-125 is less than or equal to 
35 IU/ml (Rooth, 2013).  In early stages of ovarian cancer, CA-125 levels are elevated in about 
50% of cases.  Levels are elevated in over 80% of cases of advanced disease.  Assessing change 
in CA-125 levels over time may be more reliable (Carlson, 2016).  Elevated CA-125 levels 
warrant further investigation.   
HE4 is another biomarker for ovarian cancer, with similar sensitivity as CA-125.  HE4 is 
less likely than CA-125 to be elevated in benign disease (Carlson, 2016).  In the U.S., HE4 is 
used for disease recurrence and progression, not screening (Carlson, 2016; Doubeni et al., 2016; 
Slatnik & Duff, 2015).   
Ultrasound 
Transvaginal ultrasonography is a method used to detect ovarian cancer.  The size of 
ovaries and morphologic characteristics can be visualized (Carlson, 2016).  The sensitivity for 
differentiating benign and malignant lesions is 86 to 94%.  Specificity ranges from 94 to 96% 
(Doubeni et al., 2016).   
Healthcare Professionals’ Knowledge of Ovarian Cancer 
Among healthcare professionals, there are large gaps in knowledge regarding ovarian 
cancer (Gajjar, Ogden, Mujahid, & Razvi, 2012).  Information from nurses, NP students, and 
practicing healthcare providers regarding their knowledge about ovarian cancer has been 
obtained through several research studies.  Two different groups of researchers, Gajjar et al. 
(2012) and Goldstein, Susman, Lockwood, Medlin, and Behbakht (2015) assessed healthcare 
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providers’ awareness about symptoms and risk factors of ovarian cancer.  Loerzel, Hunt, and 
Rash (2015) assessed NP students’ knowledge prior to, immediately after, and approximately 
five months after ovarian cancer education.   
From 2008-2009, Gajjar et al. (2012) studied responses of 110 general practitioners (GP) 
in the U.K. about their awareness of symptoms and risk factors of ovarian cancer.  GPs answered 
questions on symptoms, diagnosis, and risk factors.  Very few GP respondents (6.4%) indicated 
that women had symptoms in the early stages of ovarian cancer.  More than half of GPs correctly 
responded that early diagnosis of ovarian cancer is possible.  Of the GPs who participated, 26.4% 
indicated that women with the disease are more likely to experience symptoms that are very 
frequent, persistent, and sudden.  When asked about symptom frequency, 19.8% of respondents 
correctly identified that symptoms are often experienced 12-30 times per month.  Regarding the 
importance of a family history, 96.4% of respondents knew that a family history of ovarian 
cancer increased a woman’s risk although only 80.9% knew that a family history of breast cancer 
is a risk factor.  Symptoms of abdominal swelling, abdominal bloating, and pelvic pain were 
identified among respondents as relevant symptoms of ovarian cancer.  Respondents did not 
assign as much significance to gastrointestinal symptoms such as altered bowel habit, 
indigestion, and early satiety.  Gajjar et al. (2012) found that among the GPs studied, a gap in 
knowledge exists about the symptoms of ovarian cancer.  Study participants were more 
knowledgeable about the importance of a family history of ovarian cancer and less 
knowledgeable about the significance of family history of breast cancer.  Gajjar et al. (2012) 
concluded that awareness about risk factors and symptoms of ovarian cancer needs to be 
increased among GPs and regular updates are important to remain current with research.   
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Goldstein et al. (2015) researched U.S. healthcare providers’ awareness of symptoms and 
risk factors of ovarian cancer at a health fair in 2013.  One hundred and eighty-eight healthcare 
providers (family practice physicians, nurses, NPs, and obstetricians/gynecologists) completed 
the survey.  Participants answered questions to identify symptoms and risk factors pertinent to 
ovarian cancer.  Goldstein et al. (2015) found that symptom recognition among healthcare 
providers ranged from 62-90%.  Only 62% of healthcare providers could identify difficulty 
eating/early satiety and pelvic/abdominal pain as symptoms of ovarian cancer.  Out of providers 
who participated, 90% were able to identify bloating and pelvic/abdominal swelling as a 
symptom.  The symptom of urinary frequency/urgency was correctly recognized by 65% of 
healthcare providers.  Unexplained changes in bowel habits and vague/persistent stomach 
discomfort (gas, nausea, indigestion) were identified as symptoms by 72% and 79%, 
respectively.  Regarding identification of risk factors of ovarian cancer, 90% of providers were 
able to identify that a personal or family history of breast, ovarian, or colon cancer is a risk 
factor.  Only 41% recognized that undesired infertility is a risk factor.  Obesity, increasing age, 
and genetic predisposition were correctly identified 61%, 70%, and 83% of the time, 
respectively.  The number of healthcare providers who believed that an abnormal Papanicolaou 
(Pap) test is an indicator of ovarian cancer was 32%.  Healthcare providers were not able to 
identify all symptoms and risk factors of ovarian cancer.  Goldstein et al. (2015) concluded that 
healthcare providers need education about symptoms of ovarian cancer.   
A study by Loerzel et al. (2015) assessed 104 NP students’ knowledge of ovarian cancer 
incidence, risk, screening, symptoms, and treatment.  A pretest was administered to assess 
baseline knowledge.  Education on ovarian cancer was presented to students.  A posttest was 
administered immediately after the education.  Another posttest was given the following 
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semester, about five months later.  NP students’ scores from the pretest to the first posttest 
increased and then decreased by the second posttest.  NP students’ scores on the second posttest 
were still significantly higher than on the pretest.  The researchers concluded that NP students 
lacked knowledge about ovarian cancer risk factors, symptomology, and screening.  Knowledge 
gained after an educational session decreases over time, pointing to the importance of continuing 
education (Loerzel et al., 2015).   
Women’s Knowledge of Ovarian Cancer 
Even larger gaps in knowledge about ovarian cancer exist among women (Goldstein et 
al., 2015).  Two different groups of researchers, Lockwood-Rayermann, Donovan, Rambo, and 
Kuo (2009) and Goldstein et al. (2015) assessed women’s knowledge of ovarian cancer.  Similar 
results were reported.   
Lockwood-Rayermann et al. (2009) discovered that among women, a knowledge deficit 
exists in regards to ovarian cancer risk factors and symptoms.  Researchers surveyed women 40 
years of age and older about ovarian cancer risk factors, symptoms, and diagnosis.  Of 1,235 
respondents, only 15% reported being “familiar” or “very familiar” with ovarian cancer 
symptoms compared to 59% who reported being “not very familiar” or “not familiar at all.”  
Less than half of respondents could recognize symptoms of ovarian cancer from a list provided.  
One question was related to the Pap test diagnosing ovarian cancer.  More than two-thirds of 
respondents believed that a Pap test could diagnose ovarian cancer.  Knowledge about risk 
factors linked to ovarian cancer was also lacking.  More than one-third of respondents reported 
that they were not sure about risk factors.  Researchers concluded women 40 years of age and 
older need to be better informed about ovarian cancer.  Nurses may be able to provide education 
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and, therefore, have an impact on early detection of ovarian cancer (Lockwood-Rayermann et al., 
2009).   
At the same health fair where researchers assessed healthcare providers’ knowledge 
about ovarian cancer, Goldstein et al. (2015) also researched women’s awareness of symptoms 
and risk factors of ovarian cancer.  Eight hundred and fifty-seven women completed the survey 
about symptoms and risk factors related to ovarian cancer.  Recognition of symptoms ranged 
from 23-72%.  Only 23% of respondents were able to identify urinary frequency or urgency as a 
symptom of ovarian cancer.  Of the women who participated, 72% were able to identify bloating 
and pelvic/abdominal swelling as a symptom.  Regarding identification of risk factors associated 
with ovarian cancer, risk factor identification ranged from 25-82%.  The number of participants 
who incorrectly believed that an abnormal Pap test is an indicator of ovarian cancer was 57%.  
Women were not able to identify all of the listed symptoms and risk factors related to ovarian 
cancer (Goldstein et al., 2015).   
Continuing Education 
Continuing education (CE) dates back to 1894 when Florence Nightingale promoted 
continued learning in nurses (Institute of Medicine, 2010).  Many healthcare professionals are 
required to complete CE to meet the requirements of their licensing and certifying agencies 
(Forsetlund et al., 2009).  The assumption has always been that CE improves healthcare.  
Cervero and Gaines (2015) found that CE improves physician performance and, to a smaller 
degree, patient health outcomes.  Moattari, Yadgari, and Hoseini (2014) concluded that 
knowledge could increase through participation in CE.  Smith, Brown, and Khanna (2009) 
concluded that the frequency of healthcare professionals’ attendance at educational meetings 
coincided with the likelihood they were to implement the desired behaviors.  The American 
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College of Chest Physicians (ACCP) recommends that CE be used to improve practice 
performance of physicians (Davis & Galbraith, 2009).  The ACCP recommends that printed 
materials should not be the only method used; instead it is recommended that both live and 
multiple media should be utilized to improve practice performance.  The ACCP also 
recommends that to improve practice performance, CE activities should be comprised of more 
than just a single exposure (Davis & Galbraith, 2009).   
A variety of educational methods can be used to present information.  Methods can 
include conferences, workshops, courses, grand rounds and teaching, journals clubs, and self-
learning with print or internet-based materials.  An educational method that is interactive is the 
most effective method to improve healthcare professional performance and patient outcomes 
(Cervero & Gaines, 2015).   
Project Framework 
A theoretical framework and/or model should guide a practice improvement project.  
Models aid in planning and evaluating projects.  A logic model visually shows the relationships 
between resources (inputs), processes (activities), and products (outputs) that lead to desired 
results (outcomes) and impacts (Erwin et al., 2016; Melle, 2016; W. K. Kellogg Foundation, 
2004).  A logic model was chosen to guide the project.  Kirkpatrick’s four-level outcome 
evaluation model addresses four levels: reaction, learning, behavior, and results (Tian, Atkinson, 
Portnoy, & Lowitt, 2010).  An adapted version of Kirkpatrick’s four-level outcome evaluation 
model guided evaluation of the project.   
Logic Model 
A logic model is a tool that can be used for program planning and evaluation (McCawley, 
2014).  The model is comprised of inputs, activities, outputs, outcomes, and impacts.  Inputs and 
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activities are the planned work while outputs, outcomes, and impacts are the intended results 
(Erwin et al., 2016; Melle, 2016; W. K. Kellogg Foundation, 2004).  The model allows for 
visualization of the relationships between resources, activities, and results (W. K. Kellogg 
Foundation, 2004).   
Kirkpatrick’s Evaluation Model 
Reaction, learning, behavior, and results are the major components of the four levels of 
Kirkpatrick’s Evaluation Model (Tian et al., 2010).  Curran and Fleet (2005) modified 
Kirkpatrick’s model to be used for evaluating CE.  The modified levels are learner satisfaction, 
learning outcomes, performance improvement, and improved patient/health outcomes (Curran & 
Fleet, 2005).  Evaluation starts with level one (learner satisfaction) and with time evaluation is 
able to move through the other three levels (Tian et al., 2010).   
Conclusion 
Ovarian cancer’s vague symptoms and lack of accurate and reliable screening tests 
contribute to a late diagnosis, which lowers the five-year survival rate (Doubeni et al., 2016).  
Healthcare professionals lack knowledge about ovarian cancer’s risk factors and symptoms 
(Gajjar et al., 2012).  The lack of knowledge points to the need for ovarian cancer education of 
healthcare professionals.  Continuing education has resulted in improvements in healthcare 
professionals’ knowledge, practice performance, and patient health outcomes (Cervero & 
Gaines, 2015; Moattari et al., 2014).  Chapter 3 will discuss the project’s mission, design, 




CHAPTER THREE. PROJECT DESIGN 
Mission 
The project originated due to a request from the husband of a former nursing student who 
succumbed to ovarian cancer.  After his wife’s death, Brent Solseng, PharmD, began a personal 
mission to increase ovarian cancer awareness.  Dr. Solseng founded the Pam Solseng Ovarian 
Cancer Endowment Fund through Dakota Medical Foundation:  
The Pam Solseng Ovarian Cancer Endowment Fund was established in 2010 in memory 
of Pam Solseng who died after a courageous battle with ovarian cancer.  This fund 
supports health-related projects and programs within Dakota Medical Foundation's 
service area, with a special emphasis on nursing and pharmacy education and ovarian 
cancer programs.  (Impact Foundation, 2016) 
Since the beginning of project planning, Dr. Solseng has been involved in brainstorming 
about how best to increase healthcare professional awareness and knowledge.  The decision was 
to present ovarian cancer research, risk factors, symptoms, screening, diagnosis, and treatment to 
healthcare professionals at a local educational conference.   
Design 
The focus of the project was to increase healthcare professionals’ knowledge about 
ovarian cancer through an educational conference.  The conference focused on presenting the 
risk factors and symptoms of ovarian cancer, areas found to be lacking in healthcare 
professionals’ knowledge (Gajjar et al., 2012; Goldstein et al., 2015; Loerzel et al., 2015).  The 
conference took place on the evening of Tuesday, November 22, 2016, and was approximately 
two hours in length.  The target audience was healthcare professionals, and it was expected that 
attendees might have included physicians, NPs, physician assistants, nurse midwives, nurses, 
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pharmacists, nursing students, and pharmacy students.  The conference was planned for an 
attendance of 50-100 people and was offered at no cost to attendees.  A logic model was used 
during the planning phase of the project to provide a visualization of the relationship between 
planned activities and results.   
Logic Model 
A logic model (Figure 1) was created for project planning.  The planned work defined 
what resources were needed for the project and what was proposed to take place.  Inputs and 
activities were used in the planning phase of the project.  The planning phase is outlined in the 
bold section of Figure 1.   
Inputs are the resources needed for the project (W. K. Kellogg Foundation, 2004).  They 
enable successful execution of the project.  The project required many inputs: personnel, time, 
finances, venue, equipment, and advertising.   
Personnel consisted of committee members, an emcee, a presenter, a survivor/caregiver 
panel, and conference assistants.  Committee members contributed ideas and expertise during 
conference planning.  The co-investigator was emcee.  Dr. Anil Potti, a medical oncologist, was 
the primary presenter.  His experience is treating patients with ovarian cancer and conducting 
ovarian cancer research.  A panel consisting of one ovarian cancer survivor and three family 
members of ovarian cancer patients spoke about their personal experiences with the disease.  
Conference assistants helped register attendees, serve food, set up technology, and clean up after 
the event.   
Projects require time.  A considerable amount of time was required for the planning and 
execution of the conference.  Committee members, the presenter, survivor/caregiver panel 
members, and conference assistants dedicated their time.   
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Funding for the project was provided through the Pam Solseng Ovarian Cancer 
Endowment Fund.  Costs for the project included printed materials, food, and supplies used 
during the conference.  Dr. Potti graciously donated his time.  Dakota Medical Foundation 
allowed use of their event center at no cost.   
A venue for the conference was sought based upon location, size, available equipment, 
and costs.  Dakota Medical Foundation’s event center was chosen as the site to host the 
conference.  The event center can hold up to 120-150 people and had the necessary equipment to 
put on an educational conference.   
Dakota Medical Foundation supplied the equipment (projector, projector screens, and 
microphones) for the conference.  A laptop was brought into the facility to display the 
PowerPoint presentation.  A video camera was provided by North Dakota State University’s 
(NDSU) Instructional Services Department to allow for recording of the conference.   
Advertising for an event is important to gain attendance.  An announcement was designed 
(Appendix B) and an event for registration of attendees was created through the website 
Eventbrite.  The conference was advertised with advanced practice providers on Sanford’s 
Advanced Practice Provider SharePoint site, within Sanford’s Roger Maris Cancer Center, and 
on the North Dakota Nurse Practitioner Association’s Facebook site.  Advertising for the event 
was also done within the College of Health Professions at NDSU.   
Inputs are used to carry out the planned activity (W. K. Kellogg Foundation, 2004).  One 
of the project’s activities included presenting an ovarian cancer conference directed towards 
healthcare professionals.  The second activity was to provide a resource for patient education.   
The ovarian cancer presentation was created by Dr. Potti.  Information provided during 
the conference was evidence-based and focused on areas in which healthcare professionals 
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lacked knowledge: risk factors and symptoms (Gajjar et al., 2012; Goldstein et al., 2015; Loerzel 
et al., 2015).  Other information presented included the different types of ovarian cancer, factors 
that reduce a woman’s risk, screening options, staging, and treatment.  The co-investigator 
reviewed the PowerPoint before the presentation to evaluate content and assure it was at a level 
appropriate for the audience.  Refer to Appendix D for an outline of the presentation.   
Since researchers found that women are not well informed about ovarian cancer, a patient 
resource was created.  Information included on the patient resource was evidence-based and 
focused on risk factors and symptoms, since women specifically lack knowledge in those areas 
(Lockwood-Rayermann et al., 2009; Goldstein et al., 2015).  Statistics for ovarian cancer were 
presented to convey importance of awareness and knowledge about the disease.  Eye-catching 
graphics were displayed to attract the reader’s attention.  Reputable resources were provided for 
a patient to reference.  The information was printed in teal and black colored ink on 4.25 x 5.5 
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Institutional Review Board Approval 
The practice improvement project was certified as exempt by the NDSU Institutional 
Review Board on October 27, 2016 (Appendix A).  Research focused on the effectiveness of an 
instructional technique.  The project qualified under Exemption Category 1: research conducted 
in established or commonly accepted educational settings, involving normal educational 
practices.  The educational conference did not involve minors and did not specifically recruit for 
special populations (pregnant women, fetuses, prisoners, cognitively impaired individuals, 
economically or educationally disadvantaged individuals).  Attendance and participation at the 
conference was voluntary.  There was minimal risk to respondents.  The conference was 
videotaped but not for research purposes.  A photograph and video release form (Appendix J) 
was signed by the presenter and each panel speaker.   
Data Collection 
In order to assess the effectiveness of an ovarian educational conference for healthcare 
professionals, pretests, posttests, and conference evaluations were administered.  Data was 
collected the evening of November 22, 2016.  Conference attendees were informed of the 
opportunity to voluntarily participate in the research portion of the project and participation 
implied consent (Appendix C).  Those who responded completed a pretest, posttest, and 
conference evaluation.  Prior to the start of the lecture, respondents were asked to complete the 
pretest (Appendix E) and participant demographic survey (Appendix F).  Upon conclusion of the 
conference, respondents were asked to complete the posttest (Appendix G) and conference 





CHAPTER FOUR. EVALUATION 
Evaluation Methods 
Evaluation of the project involved assessing whether objectives were met.  Evaluation of 
the conference and education presented at the conference was measured through a pretest, 
posttest, and conference evaluation survey.   
Objective One 
The first objective was to design, organize, and offer a local ovarian cancer educational 
conference for healthcare professionals.  Conference planning and evaluation was guided by a 
logic model.   
Objective Two 
Objective two was to increase awareness and knowledge about ovarian cancer among 
healthcare professionals.  Education about ovarian cancer risk factors and symptoms were 
delivered during the conference.  Evaluation was completed through analysis of pretest and 
posttest results which assessed the respondents’ level of knowledge gained.   
Objective Three 
The third objective was to provide healthcare professionals with a resource for patient 
education.  An ovarian cancer resource was created for healthcare professionals to share with 
patients.  Content was created utilizing current evidence-based data and focused on risk factors 
and symptoms of ovarian cancer.  Evaluation of objective three was accomplished through the 
question “After this conference, how confident are you in your ability to educate women about 




Outputs are the result of activities (W. K. Kellogg Foundation, 2004).  An output of the 
conference was the delivery of awareness and knowledge about ovarian cancer.  The aim of the 
conference was to increase awareness and knowledge among healthcare professionals.  The goal 
of the patient resource was to increase women’s awareness and knowledge about ovarian cancer.   
Outcomes are the changes that result from the program (W. K. Kellogg Foundation, 
2004).  The expected outcomes of the conference included an increase in awareness of ovarian 
cancer, knowledge of ovarian cancer risk factors and symptoms, and recommendations for future 
ovarian cancer educational programs.   
Impacts are the changes that are expected at the organizational, community, or system 
level as a result of activities (W. K. Kellogg, 2004).  The conference was expected to have a 
community impact.  Through increasing healthcare professional awareness and knowledge of 
ovarian cancer, the expectation is that an improvement of health outcomes of women will result.   
Kirkpatrick’s Evaluation Model 
The project was also evaluated by using the modified version of Kirkpatrick’s Evaluation 
Model.  For the first level, learner satisfaction, a conference evaluation survey was used to 
evaluate respondents’ perceptions of the conference.  Respondents were asked to evaluate the 
presenter, presentation, content, and panel.  The second level is learning outcomes.  An 
evaluation of knowledge learned assisted in determining conference effectiveness.  Analysis of 
pretests and posttests was used to gauge knowledge.  The third level is an evaluation of how the 
education has affected the performance of the healthcare professional.  The fourth, and final, 
level evaluates the patient outcomes because of the education (Curran & Fleet, 2005).  The third 
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and fourth levels of the modified version of Kirkpatrick’s model were not evaluated in the time 




CHAPTER FIVE. RESULTS 
Presentation of Findings 
Data was collected during the ovarian cancer conference which took place the evening of 
November 22, 2016.  The conference was attended by 35 healthcare professionals and seven 
other individuals, which included a speaker, panel speakers, and family members and friends of 
panel speakers.  There were 29 respondents who fully completed the pretest, posttest, and 
conference evaluation.   
Demographics 
Respondents were asked to provide demographic information regarding primary 
professional role (Appendix F).  The majority of respondents were undergraduate nursing 
students (n=15).  Other respondents included graduate nursing students (n=3), registered nurses 
(n=4), pharmacy students (n=4), and pharmacists (n=2).  The professional background of one 
respondent was not defined.  Figure 2 provides the breakdown of the primary professional role of 




Figure 2. Respondent demographics 
Pretests and Posttests 
Respondents were asked to complete the pretest prior to the start of the speaker’s 
presentation.  After the speaker’s presentation and the panel presentation, respondents were 
asked to complete the posttest.  A full set of questions on the pretest and posttest can be referred 
to in Appendix E and Appendix G.  Results of the pretest and posttest were compared and 
summarized in Figure 3.   
The first question on the pretest and posttest related to ovarian cancer mortality.  Before 
the conference, 100% (n=29) of respondents correctly answered the question.  Approximately 
93% (n=27) of respondents correctly answered the question after the conference.   
The second question related to ovarian cancer screening.  Prior to the conference, 
approximately 66% (n=19) of respondents correctly identified that screening for ovarian cancer 
is not recommended in women of average-risk.  The percentage decreased to approximately 59% 
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The third question related to early symptoms of ovarian cancer.  Approximately 76% 
(n=22) of respondents answered the question correctly on the pretest.  After the conference, 
approximately 93% (n=27) of respondents chose the correct response.   
The fourth question related to risk factors for the development of ovarian cancer.  Prior to 
the conference, approximately 28% (n=8) of respondents answered the question correctly.  
Approximately 79% (n=23) of respondents correctly answered the question after receiving 
education during the conference.   
The last question on the pretest and posttest related to the examination and testing for 
ovarian cancer.  Approximately 97% (n=28) of respondents correctly answered the question on 
the pretest and posttest.  Knowledge remained the same before and after education presented at 
the conference.   
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Respondents were asked to evaluate several aspects of the conference (Appendix H).  The 
presenter, Dr. Potti, was rated on enthusiasm, interaction with the audience, and knowledge of 
the topic.  Figure 4 depicts the responses.  Twenty-one respondents rated his enthusiasm as 
“excellent,” seven respondents rated his enthusiasm as “very good,” and one respondent rated his 
enthusiasm as “good.”  As for the presenter’s interaction with audience, 21 respondents rated his 
interaction as “excellent,” seven respondents rated it as “very good,” and one respondent rated 
his interaction as “needs work.”  Twenty-six respondents rated his knowledge as “excellent” and 
three rated his knowledge as “very good.”   
 
Figure 4. Presenter evaluation 
The presentation was rated on organization, relative information, and quality of 
audiovisual material.  Responses are depicted in Figure 5.  Twenty-four respondents rated the 
organization as “excellent” and five respondents rated it as “very good.”  Twenty-two 
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five respondents rated it as “very good,” and two respondents rated it as “good.”  Twenty 
respondents rated the quality of the audiovisual as “excellent,” six respondents rated it as “very 
good,” two rated it as “good,” and one respondent rated it as “needs work.”   
 
Figure 5. Presentation evaluation 
The conference content was rated on the appropriateness of the volume and complexity 
of the information, evidence-based content, and content relevancy to practice.  Figure 6 depicts 
the responses.  Twenty-three respondents rated the volume and complexity of information as 
“excellent,” five respondents rated it as “very good,” and one respondent rated it as “good.”  
When rating the evidence-based content, 24 respondents rated it as “excellent,” four respondents 
rated it as “very good,” and one respondent rated it as “good.”  Twenty-four rated the relevance 
to practice as “excellent,” four respondents rated it as “very good,” and one respondent rated it as 

















Figure 6. Content evaluation 
Conference respondents were asked to rate the extent to which the panel’s discussion 
contributed to their overall learning.  Twenty-one respondents rated the panel “excellent” and 
eight respondents rated the panel “very good” (Figure 7).  Respondents were also asked, “How 
confident are you in your ability to educate women about ovarian cancer?”  Eighteen reported 
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Figure 7. Panel evaluation 
 
Figure 8. Confidence in education ability 
This chapter presented the project’s results.  An interpretation of the project’s results is 
provided in the next chapter.  Project limitations, recommendations, implications for future 
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CHAPTER SIX. DISCUSSION AND RECOMMENDATIONS 
The objectives of this project were to 1) design and organize a local ovarian cancer 
educational conference for healthcare professionals, 2) increase awareness and knowledge about 
ovarian cancer among regional healthcare professionals, and 3) provide healthcare professionals 
with a resource for patient education.  This chapter offers an interpretation of conference results, 
project limitation, and recommendations.  Also discussed are implications for practice, 
implications for future research, and application to NP role.   
Interpretation of Results 
All three objectives of the practice improvement project were achieved.  The conference 
was successfully implemented and some gains in knowledge were observed.  Overall, the 
ovarian cancer educational conference appeared to be an effective educational method for 
attendees.   
Objective One 
Conference evaluation was guided by a logic model.  Evaluation included the conference 
outputs, outcomes, and impacts, outlined in the bold section of Figure 9.  The conference was 
attended by 35 healthcare professionals.  Respondents’ correct responses increased on the 
posttest in the areas of ovarian cancer risk factor and symptom recognition.  More than 60% of 
respondents reported feeling very confident in their ability to educate women about ovarian 
cancer.  The impact of the conference is unknown in the time frame of this project.  The hope is 
that through the conference there will be an improvement in health outcomes of women with 
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The pretest and posttest assessed the speaker’s and panel members’ capability of 
increasing respondents’ knowledge during the conference.  When comparing answers to all 
questions, the number of correct responses increased from 106 on the pretest to 122 on the 
posttest.  After the conference, there was an increase in correct responses on questions (Q) Q3 
and Q4.  There was a decrease in correct responses on Q1 and Q2. The number of correct 
responses stayed the same on Q5.   
When comparing the pretest and posttest answers for Q1, there was a decrease in correct 
answers immediately after the educational PowerPoint presentation.  On the pretest, 100% 
(n=29) of respondents answered the question correctly, leaving no room for improvement on the 
posttest.  During the presentation, the speaker did not discuss that routine screening for ovarian 
cancer in women of average risk is not recommended which may account for the decrease in 
knowledge on the posttest.   
Knowledge about ovarian cancer screening decreased immediately after the educational 
PowerPoint presentation.  As stated previously, only approximately 59% (n=17) of respondents 
were aware that screening for ovarian cancer in women of average risk is not recommended.  
This could be due to the speaker not discussing screening recommendations during the 
presentation.   
Prior to the educational conference, approximately 76% (n=22) of respondents were able 
to correctly identify symptoms of ovarian cancer.  The results are consistent with Goldstein et al. 
(2015), who found that healthcare providers’ knowledge of symptom recognition ranged from 
62-90%.  Knowledge increased and approximately 93% (n=27) of respondents were able to 
correctly identify symptoms after receiving education.   
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As mentioned in Chapter 5, respondents’ knowledge about risk factors of ovarian cancer 
was very low prior to the conference.  The results are consistent with research by Loerzel et al. 
(2015), who found that NP students’ knowledge of ovarian cancer risk factors is lacking.  The 
number of respondents who were able to identify factors that increase a woman’s risk of 
developing ovarian cancer increased over 50%.   
When comparing knowledge about exams and testing for ovarian cancer, knowledge 
remained the same on the pretest and posttest.  There was little room for improvement as 28 
respondents answered the question correctly on the pretest.  A different respondent answered the 
question incorrectly on the posttest than on the pretest.   
The results of the pretest and posttest may have been skewed by several factors.  
Undergraduate nursing students had recently heard Dr. Brent Solseng give a classroom lecture on 
ovarian cancer.  Ovarian cancer facts were presented on the table tents at the conference, which 
could have skewed the results on the pretest and posttest.  Conference attendees also received a 
patient resource handout upon registering at the conference.  The patient resource handout 
contained ovarian cancer facts, which could have altered results of the pretest and posttest.  Q1, 
Q2, Q3, and Q4 could have been answered by referencing the table tents and the patient resource 
handout.   
Kirkpatrick’s Evaluation Model was used to evaluate the education presented.  The first 
level of Kirkpatrick’s Evaluation Model, learner satisfaction, was used to evaluate the 
respondents’ perceptions of the conference.  Overall, respondents reported a high level of 
satisfaction with the presenter, presentation, content, and panel discussion.  The second level of 
Kirkpatrick’s Evaluation Model, learning outcomes, evaluated the knowledge gained as a result 




An ovarian cancer educational resource was created and distributed at the conference.  
Thirty attendees took a handout.  On the conference evaluation, respondents were asked, “How 
confident are you in your ability to educate women about ovarian cancer?”  Of the respondents, 
62% (n=18) reported they were “very confident” and 38% (n=11) reported they were “somewhat 
confident.”  Evaluation of the impact of the patient resource was beyond the scope of this study.   
Limitations 
Limitations of the project design and execution of the practice improvement project exist.  
One of the limitations was a relatively small number of attendees and respondents.  There was 
also a lack of healthcare providers in attendance.  Advertising for the event was also a challenge.  
Another limitation was the speaker not mentioning important educational information.   
An increase in the sample size would have provided results that are more accurate.  
Forty-two individuals attended the conference.  Thirty-six attendees were healthcare 
professionals, seven of whom did not complete the pretest and posttest or did not complete them 
in their entirety.  Only 29 pretests, posttests, and evaluations were completed.  Eight 
undergraduate nursing students, who were unable to attend, were able to watch the videotape of 
the conference and complete the pretest, posttest, and evaluation.  All eight students chose not to 
complete the pretest, posttest, or the evaluation.   
The majority of respondents were undergraduate nursing students.  Much of recently 
published research about examining healthcare professionals’ knowledge about ovarian cancer is 
in reference to healthcare providers (physicians, physician assistants, NPs, and nurse midwives).  
The lack of CE credits available for conference attendance may have been a deterrent for some 
providers.  As mentioned before, offering CE credit at educational conferences improves 
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attendance (Lefebvre et al, 2013).  Due to a lack of resources (financial and time), CE credit was 
not obtained.   
Attendance at the conference could have been increased with more advertising and by 
advertising sooner.  Advertising for the conference was challenging.  Since the conference was 
not affiliated with either of the large healthcare institutions in Fargo, ND, advertising within 
those institutions was difficult.  The conference was advertised with advanced practice providers 
on Sanford’s Advanced Practice Provider SharePoint site, within Sanford’s Roger Maris Cancer 
Center, and with students and faculty within the College of Health Professions at NDSU.  An 
attempt was made to advertise at North Dakota nursing associations and nursing programs at 
local colleges within the geographical area.  Advertising with a state nursing association could 
not be accomplished, as their policy is not to advertise for events that they do not sponsor.  
Emails to nursing programs at local colleges were not returned.   
During the presentation, the speaker did not mention an important piece of information 
regarding ovarian cancer screening.  Screening for ovarian cancer in women of average risk is 
not recommended (Doubeni et al., 2016; Qaseem et al., 2014; Wilt et al., 2015).  Screening 
options for ovarian cancer were discussed by the speaker, but it was not stated that screening 
average risk women is not recommended.   
Recommendations 
Due to the increase in correct responses on questions relating to ovarian cancer, as 
evidenced by comparing the posttests to the pretests, it is practical to recommend the ovarian 
cancer educational conference as a method to increase healthcare providers’ knowledge of 
ovarian cancer.  Room for improvement certainly exists.  Recommendations for improvement 
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have been identified in order to increase healthcare professionals’ awareness and knowledge 
about ovarian cancer.   
The establishment of an annual ovarian cancer educational conference for healthcare 
professionals would likely further increase knowledge and awareness.  Smith et al., (2009) have 
concluded that the frequency of attendance at educational events correlated with the likelihood of 
desired behaviors of healthcare professionals.  In order to improve practice, the ACCP 
recommends that continuing education should consist of more than one exposure (Davis & 
Galbraith, 2009).  By presenting information annually, healthcare professionals could receive 
updated information related to ovarian cancer.   
Other improvements to the practice improvement project could be made.  Approaches 
should focus on increasing attendance and increasing the number of attendees who are healthcare 
providers.  In order to increase attendance and increase variety of professional background of 
attendees, the conference could be added to another healthcare event or conference.  Another 
option would be to collaborate with a healthcare facility within the geographical region.  As 
mentioned before, since turnout at an educational conference is increased when attendees have 
the opportunity to receive CE credits, the conference should offer approved CE credit (Lefebvre 
et al, 2013).  Gaining CE approval may be easier to obtain by collaborating with a healthcare 
facility.  In order to reach more individuals, who would otherwise be unable to attend, the 
conference could also be presented in a live webinar format.   
Ovarian cancer education could be disseminated during gatherings of healthcare 
professionals, such as the North Dakota Nurse Practitioner Association’s annual pharmacology 
conference and the North Dakota Academy of Physician Assistants’ annual primary care 
seminar.  Table tents with ovarian cancer information could be displayed on conference tables.  
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The video recording of the conference could be shared with healthcare professionals currently in 
practice as well as students in the healthcare field.  Provider education could be offered in person 
or by video feed in a clinic over the lunch hour.  Healthcare professionals working in a rural 
setting could join the noon conference via live video feed or the video could be offered on an as-
needed basis on the employee education site.   
There are various methods to create awareness and educate a diverse audience.  Ovarian 
cancer seminars could be offered in the community to any interested public, private, or religious 
group, either as stand-alone events or at a community event, such as the Women’s Showcase.  
The ovarian cancer handout created for this project or other ovarian cancer education materials 
could be placed in clinic waiting rooms or exam rooms.  Pamphlets, educational material, 
bracelets, ribbons, stickers, or other ovarian cancer awareness products could be displayed at a 
variety of venues.   
Implications for Practice 
The results of the project support the need for increased ovarian cancer education among 
healthcare professionals.  Knowledge about risk factors and symptoms of ovarian cancer and 
current screening guidelines and diagnostic tests for ovarian cancer are important for early 
detection.  Awareness and knowledge of ovarian cancer can lead to early detection and may 
improve health outcomes in women diagnosed with ovarian cancer.  When healthcare providers 
are more aware and knowledgeable about ovarian cancer, they are also able to educate women 
about the disease.   
Dissemination 
Dissemination of research findings is important to projects and provides a means to 
improve practice.  The project’s plan was presented at the NDSU College of Health Professions 
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Poster Presentation in April 2016 and at the North Dakota Nurse Practitioner Association 
Pharmacology Conference poster presentation in September 2016.  The results of the ovarian 
cancer conference project were presented at the NDSU College of Health Professions Poster 
Presentation in March 2017.  The videotape of the conference could be used as a means of 
dissemination.  An executive summary of the project can be found in Appendix K.   
Implications for Future Research 
Further research projects on ovarian cancer education could involve the education of 
women.  As stated earlier, women lack knowledge about ovarian cancer, specifically risk factors 
and symptoms of the disease (Goldstein et al., 2015; Lockwood-Rayermann et al., 2009).  
Women who are aware of the disease, either through personal experience or by knowing a 
woman with ovarian cancer, were more knowledgeable about the disease (Lockwood-
Rayermann et al., 2009).  Education presented to women about ovarian cancer is likely to 
increase awareness and knowledge.  An increase in awareness and knowledge about ovarian 
cancer may lead to earlier diagnosis.   
Since the outcome of the patient resource handout was beyond the scope of this study, 
future research could focus on the outcome of the ovarian cancer educational handout for 
women.  The third and fourth levels of Curran and Fleet’s (2005) modified version of 
Kirkpatrick’s Evaluation Model could be used to evaluate the education.  Project evaluation 
could be developed that measures change in healthcare professional performance and patient 
outcomes.   
Application to Nurse Practitioner Role 
NPs, practicing in a variety of healthcare settings, provide care to women.  Many NPs 
work in primary care and are gatekeepers to women’s healthcare.  They have the opportunity to 
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recognize risk factors and early symptoms of ovarian cancer in their female patients.  Early 
detection is associated with improved outcomes (Slatnik & Duff, 2015).  NPs are well known for 
providing health education (American Association of Nurse Practitioners, 2017).  They have the 
opportunity to educate women about risk factors and symptoms of ovarian cancer.  As providers, 
educators, and advocates, NPs have the opportunity to enhance health outcomes of women with 
ovarian cancer.   
Conclusion 
As a result of the subtle symptoms of ovarian cancer and late stages at diagnosis, 
education of healthcare professionals about ovarian cancer is paramount.  With knowledge about 
ovarian cancer lacking, creating educational opportunities for healthcare professionals may fill 
the gaps.  Providing an ovarian cancer educational conference is one way to improve awareness 
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APPENDIX C. INVITATION FOR CONFERENCE PARTICIPATION 
NDSU North Dakota State University 
  Department of Nursing 
  1919 N University Drive 
  NDSU Dept. 2670 
  PO Box 6050 
  Fargo, ND 58108-6050 
  (701) 231-7395 
 
Increasing Awareness and Knowledge About Ovarian Cancer to Enhance Health 
Outcomes of Women 
 
Dear Conference Participant: 
 
My name is Elizabeth Hodny. I am a graduate student in the Doctor of Nursing Practice program 
at North Dakota State University, and I am conducting a research project to increase awareness 
and knowledge about ovarian cancer among healthcare professionals. It is our hope, that with 
this research, we will learn more about how to increase awareness and knowledge about ovarian 
cancer.  
 
Because you are healthcare professional, you are invited to take part in this research project. 
Your participation is entirely your choice, and you may change your mind or quit participating at 
any time, with no penalty to you. 
 
It is not possible to identify all potential risks in research procedures, but we have taken 
reasonable safeguards to minimize any known risks.  
 
By taking part in this research, you may benefit by gaining a better understanding of ovarian 
cancer. Benefits to others are likely to include advancement of knowledge. However, you may 
not get any benefit from being in this study. 
 
It should take about 5-10 minutes to complete the questions in the pre- and post-tests and 
conference evaluation form.  
 
We will keep private all research records that identify you. Your information will be combined 
with information from other people taking part in the study, we will write about the combined 
information that we have gathered. You will not be identified in these written materials. We may 
publish the results of the study; however, we will keep identifying information private. 
 
If you have any questions about this project, please contact me at (218) 686-9660 or 
elizabeth.hodny@ndsu.edu, or contact my advisor Dr. Tina Lundeen at (701) 231-7747 or 
tina.lundeen@ndsu.edu. You have rights as a research participant. If you have questions about 
your rights or complaints about this research, you may talk to the researcher or contact the 
NDSU Human Research Protection Program at 701.231.8995, toll-free at 1-855-800-6717, by 
email at ndsu.irb@ndsu.edu, or by mail at:  NDSU HRPP Office, NDSU Dept. 4000, P.O. Box 
6050, Fargo, ND 58108-6050. 
 
Thank you for taking part in this research.  
Sincerely,  
 
Elizabeth Hodny, RN, BSN, DNP-S  
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APPENDIX D. OVARIAN CANCER PRESENTATION OUTLINE 
 Objectives 
 Identify risk factors for ovarian cancer 
 Recognize symptoms of ovarian cancer  
 Discuss ovarian cancer screening recommendations 
 Discuss the different stages of ovarian cancer 
 Identify treatment options for ovarian cancer 
 What is ovarian cancer? 
 Types of ovarian cancer 
 Genetics 
 Risk factors 
 Increased risk 
 Protective factors 
 Presentation 
 Screening and early detection 
 Stages 
 Stage 1 
 Stage 2 
 Stage 3  
 Stage 4 
 Treatment 
 Surgery 
 Chemotherapy  
 56 
 
APPENDIX E. PRE-TEST 
1. What features contribute to the mortality of ovarian cancer? 
a. Lack of routine screening recommendations 
b. Vague symptoms 
c. Diagnosis in late stages 
d. All of the above 
 
2. Screening women of average risk for ovarian cancer is: 
a. Recommended using the CA-125 tumor biomarker test 
b. Recommended using transvaginal ultrasonography 
c. Not recommended 
d. A and B 
 
3. Early symptoms of ovarian cancer include all of the following EXCEPT:  
a. Change in bowel habits 
b. Early satiety 
c. Bloating 
d. Change in vulva color 
e. Pelvic/abdominal pain 
 
4. What factors increase a woman’s risk of developing ovarian cancer? (Select all that 
apply) 
a. Late menarche 
b. Family history of breast cancer 
c. Late menopause 
d. Nulliparity  
e. Oral contraceptive pill use 
f. Family history of ovarian cancer 
 
5. What assessments should be performed or what tests should be ordered if a patient is 
suspected to have ovarian cancer? 
a. Physical exam (pelvic exam) 
b. CA-125 tumor biomarker test 
c. Transvaginal ultrasonography 






APPENDIX F. RESPONDENT DEMOGRAPHICS 
Primary professional role (check one): 
 Student:  
 ____ nursing – undergraduate 
 ____ nursing – graduate 




 ____ RN 
  
 Advanced Practice RN:  
  ____ Nurse Practitioner 
 ____ Nurse Midwife 
 ____ Clinical Nurse Specialist 
  























APPENDIX G. POST-TEST 
1. What features contribute to the mortality of ovarian cancer? 
a. Lack of routine screening recommendations 
b. Vague symptoms 
c. Diagnosis in late stages 
d. All of the above 
 
2. Screening women of average risk for ovarian cancer is: 
a. Recommended using the CA-125 tumor biomarker test 
b. Recommended using transvaginal ultrasonography 
c. Not recommended 
d. A and B 
 
3. Early symptoms of ovarian cancer include all of the following EXCEPT:  
a. Change in bowel habits 
b. Early satiety 
c. Bloating 
d. Change in vulva color 
e. Pelvic/abdominal pain 
 
4. What factors increase a woman’s risk of developing ovarian cancer? (Select all that 
apply) 
a. Late menarche 
b. Family history of breast cancer 
c. Late menopause 
d. Nulliparity  
e. Oral contraceptive pill use 
f. Family history of ovarian cancer 
 
5. What assessments should be performed or what tests should be ordered if a patient is 
suspected to have ovarian cancer? 
a. Physical exam (pelvic exam) 
b. CA-125 tumor biomarker test 
c. Transvaginal ultrasonography 










*Correct answers are in bold type  
 59 
 
APPENDIX H. CONFERENCE EVALUATION 
Please rate the following according to the scale: 
1 – needs work 
2 – good 
3 – very good 











Enthusiasm     
Interaction with audience     











The information was presented in an 
organized manner 
    
Related information to practical problems     











The volume and complexity of the 
information was appropriate 
    
Content was evidence-based     
Content was relevant to practice     
 









Discussion contributed to overall learning     
 
After this conference, how confident are you in your ability to educate women about 
ovarian cancer? (circle one) 
Not confident                A little confident                Somewhat confident                Very confident  
 
(Wood, Marks, & Jabbour, 2005)  
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APPENDIX J. PHOTOGRAPH AND VIDEO RELEASE FORM 
I hereby grant permission to the rights of my image, likeness and sound of my voice as recorded 
on audio or video tape without payment or any other consideration.  I understand that my image 
may be edited, copied, exhibited, published or distributed and waive the right to inspect or 
approve the finished product wherein my likeness appears. Additionally, I waive any right to 
royalties or other compensation arising or related to the use of my image or recording.  I also 
understand that this material may be used in diverse educational settings within an unrestricted 
geographic area.  
 
Photographic, audio or video recordings may be used for the following purposes: 
 conference presentations 
 educational presentations or courses 
 informational presentations 
 on-line educational courses 
 educational videos 
 
By signing this release, I understand this permission signifies that photographic or video 
recordings of me may be electronically displayed via the Internet or in the public educational 
setting. 
 
I will be consulted about the use of the photographs or video recording for any purpose other 
than those listed above. 
 
There is no time limit on the validity of this release nor is there any geographic limitation on 
where these materials may be distributed. 
 
This release applies to photographic, audio or video recordings collected as part of the sessions 
listed on this document only. 
 
By signing this form, I acknowledge that I have completely read and fully understand the above 
release and agree to be bound thereby. I hereby release any and all claims against any person or 
organization utilizing this material for educational purposes. 
 
Full Name___________________________________________________  
 




Prov/Postal Code/Zip Code______________________________________ 
 








If this release is obtained from a presenter under the age of 19, then the signature of that 
presenter’s parent or legal guardian is also required. 
 





APPENDIX K. EXECUTIVE SUMMARY 
Background 
Ovarian cancer is the fifth leading cause of cancer death among women in the U.S. and 
kills approximately 14,000 women each year (Nezhat et al., 2015).  Survival increases with early 
diagnosis; the five-year survival rate in stage I is 90%.  Symptoms are vague and common to 
many health diseases, which may well explain why upwards of 70% of women with ovarian 
cancer are diagnosed at stage III or IV (Slatnik & Duff, 2015).  Preventative guidelines in the 
U.S. do not recommend screening for ovarian cancer in women of average risk (AAFP, 2016b; 
ACOG, 2011; Doubeni et al., 2016; Moyer, 2012; NCCN, 2015; Qaseem et al., 2014; Wilt et al., 
2015).  A lack of screening recommendations and a subtle presentation point to the need for 
greater healthcare professional recognition of symptoms and risk factors of ovarian cancer, 
which can then lead to a prompt diagnosis.   
While healthcare professionals have the opportunity to improve health, gaps in 
knowledge exist related to ovarian cancer risk factors and symptom recognition (Gajjar et al., 
2012).  Continuing education improves healthcare professionals’ performance and patient health 
outcomes (Cervero & Gaines, 2015).  Increasing healthcare professionals’ knowledge of ovarian 
cancer may help to detect ovarian cancer in earlier stages and enhance health outcomes of 
women.   
Project Summary 
Based on the ovarian cancer knowledge deficit among healthcare professionals, an 
ovarian cancer educational conference was developed and presented to healthcare professionals.  
The conference focused on presenting risk factors and symptoms of ovarian cancer.  The 
conference was offered on a weekday evening for approximately two hours and was provided at 
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no cost to attendees.  The target audience was healthcare professionals, to include physicians, 
NPs, physician assistants, nurse midwives, nurses, pharmacists, nursing students, and pharmacy 
students.  Since women also are not well informed about ovarian cancer, an ovarian cancer 
patient resource was created and distributed at the conference to assist in educating patients.   
Results 
The conference was evaluated through a pretest, posttest, and conference evaluation 
survey.  Data regarding type of primary professional role was collected, as well, during the 
conference.  The conference was attended by 35 healthcare professionals, 29 of whom responded 
to the pretest, posttest, and evaluation survey.  The majority of respondents were undergraduate 
nursing students (n=15).  Other respondents included graduate nursing students (n=3), registered 
nurses (n=4), pharmacy students (n=4), pharmacists (n=2), and not defined (n=1).   
After the conference, correct responses increased in the areas of risk factor and symptom 
recognition.  The number of correct responses remained the same regarding exams and testing 
for ovarian cancer.  The number of correct responses decreased in the areas of ovarian cancer 
mortality and screening.  Conference respondents were asked to rate the extent to which the 
panel’s discussion contributed to their overall learning.  Twenty-one respondents rated the panel 
“excellent” and eight respondents rated the panel “very good.”  Respondents were also asked 
“How confident are you in your ability to educate women about ovarian cancer?”  Eighteen 
reported they were “very confident” and 11 reported they were “somewhat confident.”  Overall, 
the respondents indicated the ovarian cancer conference had a positive impact on attendees and 




Due to the increase in correct responses on questions relating to ovarian cancer, as 
evidenced by comparing the posttests to the pretests, it is practical to recommend the ovarian 
cancer educational conference as a method to increase healthcare providers’ knowledge of 
ovarian cancer.  Room for improvement often exists.  Recommendations for improvement have 
been identified in order to increase healthcare professionals’ awareness and knowledge about 
ovarian cancer.   
The establishment of an annual ovarian cancer educational conference for healthcare 
professionals would likely further increase knowledge and awareness.  As Smith et al., (2009) 
concluded, the frequency of attendance at educational events correlated with the likelihood of 
desired behaviors of healthcare professionals.  In order to improve practice, the ACCP 
recommends that continuing education should consist of more than one exposure (Davis & 
Galbraith, 2009).  By presenting information annually, healthcare professionals could receive 
updated information related to ovarian cancer.   
Other improvements to the practice improvement project could be made.  Approaches 
should focus on increasing attendance and increasing the number of attendees who are healthcare 
providers.  In order to increase attendance and increase variety of professional background of 
attendees, the conference could be added to another healthcare event or conference.  Another 
option would be to collaborate with a healthcare facility within the geographical region.  As 
mentioned before, since turnout at an educational conference is increased when attendees have 
the opportunity to receive CE credits, the conference should offer approved CE credit (Lefebvre 
et al, 2013).  Gaining CE approval may be easier to obtain by collaborating with a healthcare 
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facility.  In order to reach more individuals, who would otherwise be unable to attend, the 
conference could also be presented in a live webinar format.   
